TrialClinical and molecular hepatology2015

Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea.

Suh Yoon Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.